About
Amy A. Wendell is Senior Vice President of Strategy and Business Development of Covidien plc, a position she has held since December 2006. In this position, Ms. Wendell manages all business development, including acquisitions, divestitures and licensing/distribution, and leads the Company’s strategy and portfolio management initiatives. She played a key role in managing the acquisitions of ev3, Sherwood Davis & Geck, U.S. Surgical, Mallinckrodt and more than 60 other transactions for Covidien (formerly known as Tyco Healthcare). In addition, Ms. Wendell is involved with organic growth initiatives, specifically focusing on new product development. She and a team of colleagues developed and implemented a new stage-gate product development process that has been established across the organization. Ms. Wendell joined the Kendall Healthcare Products Company, the foundation of the Covidien business, in 1986 as a Development Engineer. For the next five years, she held various positions, i
Position in the VCSift Database
- • 5 investors at Covidien Ventures are tracked.
- • 1 investors hold the Senior Vice President, Strategy & Business Development role in VCSift. Amy A. Wendell is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Amy
Search Investors